Clinical trial NCT01276392 - References

Kidney Replacement Disorder — Anticoagulation and Activation - Comparison in Continuous Renal Replacement Therapy

Citation(s)

•   Bouman CS, de Pont AC, Meijers JC, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M, de Jonge E
  The effects of continuous venovenous hemofiltration on coagulation activation. Crit Care. 2006;10(5):R150.
•   Davenport A
  The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis. 1997 Nov;30(5 Suppl 4):S20-7. Review.
•   Lang T, von Depka M
  [Possibilities and limitations of thrombelastometry/-graphy]. Hamostaseologie. 2006 Aug;26(3 Suppl 1):S20-9. German.
•   Sabovic M, Salobir B, Preloznik Zupan I, Bratina P, Bojec V, Buturovic Ponikvar J
  The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis. Pathophysiol Haemost Thromb. 2005;34(6):274-8.
•   Schaefer RM, Barenbrock M, Teschner M, Bahner U
  [Extracorporeal renal replacement therapies in acute renal failure]. Med Klin (Munich). 2000 May 15;95(5):273-8. Review. German.
•   Toft P, Gilsaa T
  [Acute renal failure in critically ill patients]. Ugeskr Laeger. 2007 Feb 19;169(8):692-5. Danish.

Platelet Function, Whole Blood Coagulation and Fibrinolysis During Continuous Renal Replacement Therapy - a Comparison of Citrate and Heparin Anticoagulation

Details for clinical trial NCT01276392